CMC Biologics and MacroGenics Enter into a Process Development and Manufacturing Agreement for Oncology Product Candidate

[PR Newswire] – SEATTLE, May 6, 2014 /PRNewswire/ — CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company … more

View todays social media effects on MGNX

View the latest stocks trending across Twitter. Click to view dashboard

See who MacroGenics is hiring next, click here to view